Custom Header
search icon
menu icon
Tumor-Infiltrating Lymphocytes (TIL) Therapy
TIL is a type of FDA approved cellular therapy involves collecting special white blood cells called Tumor-Infiltrating Lymphocytes from your tumor, growing them in a lab, and then returning them to your body to attack the cancer.

Tumor-Infiltrating Lymphocytes (TILs) Therapy

TIL therapy involves collecting special immune cells called Tumor-Infiltrating Lymphocytes from your tumor, growing them in a lab, and then returning them to your body to attack the cancer.

Our personalized treatment plans evolve with your cancer journey, ensuring that as your needs change, so does the level of care and support we provide. We are committed to empowering you to focus on your recovery, with treatment plans that adapt to meet your unique needs.

Tailored Assessments

Flexible Treatment Options

Personalized Care Planning

How does Tumor-Infiltrating Lymphocytes (TIL) Therapy work?

  • TIL naturally recognize and attack cancer cells.
  • In the lab, they are multiplied to increase their cancer-fighting power.
  • Once injected back into the body, they target and destroy cancer cells more effectively.
  • It is given through an infusion just like a blood transfusion.

Target Cancers

  • Melanoma and all types of solid tumors

Benefits

Personalized: Uses your own immune cells.

Effective: Especially useful for advanced cancers.

Durable Response: Can lead to long-term remission.

Benefits

Personalized: Uses your own immune cells.

Effective: Especially useful for advanced cancers.

Durable Response: Can lead to long-term remission.

Risks and Side-Effects

  • Common Side Effects: Fever, chills, fatigue.
  • Serious Risks: Infections, low blood counts, or complications from other medications used with TILs.

How is it different from traditional treatment?

This therapy is designed as a one-time process with long-lasting effects, setting it apart from traditional treatments that often require repeated interventions.

Eligibility Factors

Eligibility depends on factors such as:

  • Patients with advanced or metastatic cancer that has not responded to other treatments.
  • Good overall health to tolerate the therapy.

Success Rate

Success varies by cancer type but has shown promising results in cancers like melanoma and cervical cancer, with some patients achieving long-term remission.

During Therapy

Tumor tissue is taken through surgery or biopsy. TILs are extracted and grown in large numbers.

After Therapy

After preparing your body, TILs are re-infused through a drip.

Recovery

Regular check-ups to track progress and manage side effects.

Process

Insurance Coverage

Insurance coverage for TCR Therapy varies by provider and plan. Patients should consult with their healthcare provider and insurance company to understand coverage options and potential costs.

Next steps if T - cell Receptor (TCR) Therapy doesn’t work

Alternative options may include:

  • Other immunotherapies
  • Targeted therapies
  • Participation in additional clinical trials
  • Supportive care to manage symptoms and improve quality of life.

Approved by FDA - Click here for more details

Book an Appointment

Take the first step toward healing with expert cancer care.